Orion Oyj (OTCMKTS:ORINF – Get Free Report) shares rose 3.2% on Wednesday . The stock traded as high as $48.65 and last traded at $48.65. Approximately 200 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 1,080 shares. The stock had previously closed at $47.16.
Orion Oyj Stock Up 3.2 %
The firm’s 50 day simple moving average is $47.16 and its two-hundred day simple moving average is $47.16.
About Orion Oyj
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
Featured Articles
- Five stocks we like better than Orion Oyj
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Business Services Stocks Investing
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Stocks to Consider Buying in October
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Orion Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
